Sep 21, 2021 / 02:00PM GMT
Operator
Good morning, and welcome to the Cidara Therapeutics R&D Day. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Cidara website following the conclusion of the event.
I'd now like to turn the call over to your host, Dr. Jeff Stein, President and Chief Executive Officer of Cidara Therapeutics. Please go ahead, Jeff.
Jeffrey L. Stein - Cidara Therapeutics, Inc. - President, CEO & Executive Director
Well, thanks for the introduction, Tara, and good day, everyone. Thanks so much for attending today's event. As you can see from the agenda, we will provide some robust updates on both of our rezafungin and Cloudbreak platforms. In between, we'll have a brief interval where you can submit some written questions, and Tara will provide the detail on how to do so. But we'll kick off the program with rezafungin. Taylor Sandison, our Chief Medical Officer, will provide updates on our clinical programs, STRIVE, ReSTORE and ReSPECT.
And will be disclosing some new data from a recently
Cidara Therapeutics Inc To Host Research And Development Day Webinar Transcript
Sep 21, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers